Teal Health, Inc.

Teal Health, Inc. develops and operates the Teal Wand™, an FDA-authorized self-collection device for at-home cervical cancer screening. The company provides a telehealth-integrated cervical cancer screening service that enables women aged 25–65 to collect HPV samples privately at home using the Teal Wand, which are then analyzed using the same Primary HPV test (cobas® HPV from Roche) recommended by the American Cancer Society and U.S. Preventive Services Task Force. Clinical validation demonstrates detection of cervical precancer at 96% sensitivity, equivalent to clinician-collected samples. The service includes virtual consultations with licensed medical providers for screening history review, result interpretation, and coordination of follow-up care when abnormal results warrant referral. Teal Health operates a direct-to-consumer model with insurance integration (Cigna, Aetna, Anthem Blue Cross, Blue Cross Blue Shield, United Healthcare) and HSA/FSA eligibility. Pricing is $99 with insurance or $249 self-pay (reduced from $499). The company emphasizes accessibility and patient comfort, reporting that 94% of clinical trial participants preferred at-home screening over traditional in-office procedures. Teal Health has received recognition including TIME's Best Inventions of 2025 and endorsement from the U.S. Health Department for cervical cancer prevention through at-home screening alternatives.